Investigational Drug Details
| Drug ID: | D065 |
| Drug Name: | CC-90001 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 1403859-14-2 |
| Repositioning for NAFLD: | No |
| SMILES: | N(c1c(C(=O)N)cnc(n1)NC(C)(C)C)[C@H]1C[C@@H](O)[C@@H](CC1)C |
| Structure: |
|
| InChiKey: | QBBRJRLJWXRSHQ-CKYFFXLPSA-N |
| Molecular Weight: | 321.425 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | serine kinase inhibitor |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 terminated (NCT04048876: Business objectives have changed) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0123 | NCT04048876 | Phase 2 | Terminated | No Results Available | August 14, 2019 | October 26, 2021 | Details |
| L0998 | EUCTR2018-004431-79-FR | Phase 2 | Prematurely Ended | -- | 2019/7/2 | -- | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|